Medicine and Science from The BMJ

This week, to steal a line from the latest BMJ editor’s choice, we’ll be talking shit. The millennium development goal on sanitation is way off track; Lyla Mehta, a sociologist from the Institute of Development Studies, tells us why, and Kamal Kar, a development consultant from India, explains how his grass roots initiative changes the way people view sanitation. Also, National confidential enquir...

In this week’s podcast we find out from Sean Tunis about the future of comparative effectiveness research in the USA, and how the new institute created to champion it will differ from the UK’s National Institute of Clinical Excellence. Also, Claudia Cooper talks about her research that could support carers in the decisions they have to make for dementia sufferers.

A person’s right to refuse treatment is based on their capacity to make a rational decision – but what is the situation when someone is admitted after a suicide attempt? Can you be simultaneously rational and suicidal? Anthony David from the Institute of Psychiatry gives us his views. A second interview deals with Barrett’s oesophagus, which is on the increase. The same is true for adenocarcinoma...

In a series of articles, this spotlight focuses on recognising and managing the end of life, having the difficult conversations with patients about their death, and the importance of taking into account the spiritual aspects of death. In this podcast Duncan Jarvies talks to the authors of 2 of those articles. Professor Jane Maher, oncologist and CMO of Macmillan Cancer Support, talks about the imp...

This week we’re joined by Martin McKee, professor of European public health at the Loncon School of Hygiene and Tropical Medicine. He’s also research director of the European observatory on health systems and policies, a group that promotes evidence based healthcare policies in Europe. We’ll be discussing the effect the squeeze in funding is having on health care in Europe, and the various strateg...

Last week saw Safety 2010, the international conference on preventable accidents. We hear from some of the speakers there why safety comes second when it comes to global health. Also this week, female sexual dysfunction - fact or fiction. In advance of a BMJ debate on the topic, we get to the heart of the issue.

Last week BMJ Careers published “The new lost tribe,” describing the cohort of surgical trainees moving from ST2 to ST3. In this podcast Edward Davies, BMJ Careers editor, and Tom Dolphin, a member of the BMA junior doctors’ committee, describe how competition for training places is affecting career progression.

This week Beate Wieseler from IQWiG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) tells us how they uncovered data on the antidepressant reboxetine. Also Angela Thomas and Julia Anderson, haematologists from the Comprehensive Care Haemophilia and Thrombosis Centre, Royal Infirmary of Edinburgh, explain how to investigate a child who bruises easily.

In this week’s podcast Jayati Das-Munshi, from the Institute of Psychiatry, London, talks about her study into the mental health effects of ethnic density. Also, hyper/hypo - antonyms that can sound almost identical. Adam Frankel and Phillip Vecchio from the Princess Alexandra Hospital in Woolloongabba, Australia, explain their their plan to do away with these troublesome prefixes.

China’s New Rural Cooperative Medical Scheme, aims to provide health insurance to 800 million rural citizens. We’ll be finding out from Scott Rozelle, from Stanford University and Qingye Meng from Peking University, the background to the formation of the scheme, and its place in the wider Chinese medical system.

A BMJ investigation this week raises concerns about the ability of the US Food and Drug Administration to monitor the safety of medical devices through post-approval surveillance. We ask: is the FDA giving device manufacturers an easy regulatory ride? Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power to restrict the use of any drug that exceeds its £30...

This week the podcast’s all about risk, as we bring you two reports from Risky Business, the conference where speakers from a wide range of hazardous industries came together to share ideas. Pat Crosskerry tells Rebecca Coombes how his work shows thinking more analytically, and less intuitively, could help doctors make better diagnostic decisions, and save lives. We also look at the contentious su...

This week Dulcie McBride, a consultant in public health at University College London, joins us to talk about the UK’s practice variation in referring to secondary care. Also Simon Wright, head of health at Save the Children, the BMJ’s Christmas charity, talks to Rebecca Coombes about how the money you donate helps health care in some of the world’s poorest countries.

This week we’re joined by Jack Wennberg, author of the Dartmoth Atlas of Healthcare. He and Fiona Godlee discuss his work, and what the UK can learn from the US. Also this week what do you buy a MAMIL (Middle Aged Man in Lycra) for Christmas?

In this week’s cracker of a show… Firstly, could how you park your car indicate your choice of specialty? Secondly, how a team of scientists managed to solve the mystery of the missing French monarch. And are doctors in ITU more likely to be oliguric, and at greater risk of acute kidney injury than their patients? We read a modern fable, which has an important message for the management of complex...

In the final BMJ podcast of 2010, David Payne asks the Independent’s Jeremy Laurance about the year past, and BMJ authors how they feel going into the one ahead. Also, Adama Traore tells us about the work Save the Children are doing in Sierra Leone. The charity has been instrumental in implementing free healthcare for women and children there, and we hear about their success.

This week we find out the best way to treat a Mesobuthus tamulus (indian red scorpion) sting. We also discuss the current state of healthcare in Iraq; and how Andrew Wakefield’s article linking the MMR vaccine and autism was not bad science, but deliberate fraud.

In this week’s podcast we hear from Tom Jefferson of the Cochrane Collaboration about the problem of publication bias – and a tool that could help researchers dowse for hidden data. Also, Brian Deer discusses his features and explains why it’s been so long from the original publication of Wakefield’s work in the Lancet to the revelations just published in the BMJ. And David Payne talks to us about...

Andrew Lansley said this week his NHS reforms are needed because the UK’s health outcomes are amongst the poorest in Europe. However John Appleby, chief economist at the King’s Fund, tells us why the comparisons are flawed. We also hear from Turkey’s minister of health, Recep Akdağ, on the strides his country has made in providing healthcare.

In this week’s podcast Theresa Marteau, director of the Behaviour and Health Research Unit at the University of Cambridge, wonders if a nudge is enough to change our health behaviours. Also this week, Aziz Sheikh, from the E-medicine Group at The University of Edinburgh, explains how telemedicine is going to be an integral part of future healthcare.

In this week’s podcast Andrew Farmer from the National Institute of Health Research, Health Technology Assessment programme (NIHR HTA), tackles uncertainty. Also, Andrew Clark from the University of Hull tells us that the case for administering oxygen isn’t air tight.

This week we find out about diabetes. Mabel Chew, our Sydney based associate editor, discovers why it’s important not to miss the diagnosis of type I diabetes in children. And we learn about a new therapeutic agent for type II diabetes: glucagon-like peptide-1 analogues.

In this week’s podcast we find out from Susan Brien and Paul Ronksley about the cardioprotective effects of alcohol. Also, Annabel Ferriman tells us about the nominees for the BMJ Group lifetime achievement award.

Between March 2010 and March 2011 the cost of maize and wheat doubled. This is just the latest in a series of price hikes in food staples. In an editorial this week, Joachim Von Braun sets out some of the problems that this price rise is going to cause. David Nabarro, UN special representative of the secretary-general on food security and nutrition, describes why and how we should control the pric...

In this week’s podcast, Johan Sundstrom explains how blood pressure in adolescents effects mortality in adults. And John Appleby, chief economist of the King’s Fund, talks waiting times.